Home > Insider Trading > Filing (0000950170-24-066177)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1579428	Axsome Therapeutics Inc.	AXSM	Pharmaceutical Preparations (2834)	454241907

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1805812	L. Mark Jacobson	C/O Axsome Therapeutics, Inc. One World Trade Center, 22Nd Floor New York NY 10007	Chief Operating Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-05-29	13,693	$1.30	13,693	No	4	M	Direct
Common Stock	Disposition	2024-05-29	7,910	$74.31	5,783	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2024-05-29	13,693	$0.00	13,693	$1.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2015-08-15	2024-06-18	No	4	M	Direct

Footnotes

Represents an exercise of stock options prior to the 10-year expiration date of such options.
Represents the subsequent sale of a portion of the underlying shares of the aforementioned exercise of stock options by the reporting person through a "sell to cover" transaction to satisfy tax withholding obligations and costs in connection with the aforementioned exercise of stock options.
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $73.99 and $74.52.